Product
IGM-6268
2 clinical trials
2 indications
Indication
Healthy Control ParticipantsIndication
COVID-19Clinical trial
A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Intranasal Plus Intraoral IGM-6268 in Healthy VolunteersStatus: Terminated, Estimated PCD: 2022-06-15
Clinical trial
A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Intranasal Plus Intraoral IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19Status: Terminated, Estimated PCD: 2022-05-06